3,000,000 Shares Short - Only 23.5 Million Shares Outstanding - Price Target: $16.00
With a PDUDA date less than three months away and "big pharma" on the hunt for small cap acquisitions, it's no wonder that more than seven analysts expect the share price to more than double short term.
And the reality is that most of the outstanding shares are closely held and not part of the float. There might be only 7M shares that are truly in the float. So the short interest is really high and good luck (not really) to those shorts trying to cover this before the PDUFA. It will be interesting to see how high this goes before PDUFA. My guess is $11 and the move just started last week.